SCHEDULE: Michael Cordonnier Discloses 5.9% Stake in Carlsmed, Inc.
Beneficial Ownership Disclosure
Michael Cordonnier has reported a beneficial ownership of 5.9% of Carlsmed, Inc.'s common stock following a recent reverse stock split.
Summary
- Michael Cordonnier has filed a Schedule 13G, disclosing beneficial ownership of 1,597,752 shares of Carlsmed, Inc. Common Stock.
- This ownership represents 5.9% of the company's outstanding common stock.
- The reported share count reflects a 1-for-5.58 reverse stock split of Carlsmed, Inc.'s common stock, which was effective on July 10, 2025.
- The total beneficially owned shares consist of 1,239,330 shares of common stock and 358,422 shares of common stock issuable upon the exercise of stock options exercisable within 60 days as of July 24, 2025.
- The reported percentage is based on 26,627,635 shares of common stock outstanding as of July 24, 2025, plus the 358,422 exercisable options held by Mr. Cordonnier.
- The filing explicitly states that 112,478 shares of common stock issuable upon the vesting of RSUs (Restricted Stock Units) subject to market-based and performance-based conditions are not included in the reported beneficial ownership.
Sentiment
Score: 5
Explanation: The filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's operational or financial performance.
Positives
- The disclosure of a significant individual stake (5.9%) by Michael Cordonnier, potentially a key insider, may signal confidence in the company's future.
Future Outlook
NA
Industry Context
This filing is a standard regulatory disclosure of beneficial ownership and does not provide specific insights into broader industry trends or competitive landscape beyond the company's capital structure.
Stakeholder Impact
- Shareholders: The disclosure of a significant individual stake by Michael Cordonnier provides transparency regarding major ownership positions, which can influence investor perception and confidence.
Key Dates
| Date | Description |
|---|---|
| July 10, 2025 | Effective date of the 1-for-5.58 reverse stock split of Carlsmed, Inc.'s outstanding common stock. |
| July 24, 2025 | Date of event which requires the filing of this statement (beneficial ownership threshold reached/maintained). |
Keywords
Carlsmed Inc., Michael Cordonnier, Beneficial Ownership, Schedule 13G, Common Stock, Reverse Stock Split, Stock Options, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.